← The Wire
ANABNasdaq
ANAPTYSBIO, INC
Pharmaceutical Preparations · DE · CIK 1370053
Develops antibody product candidates for inflammation and immuno-oncology unmet medical needs
red 8-K · 90d
$1.63B
Market cap
$65.97
Last close
+4.5%
1D
+10.0%
5D
778K
Volume
Price · last 39 sessions-5.5%
May 4L $50.37 · H $69.78Jun 29
214
Total filings
Jun 29, 2026
Last filing
12/31
Fiscal year end
DEFA14ADEFA14AJun 29, 2026DEF 14ADEF 14AJun 29, 20268-KMaterial AgreementJun 22, 20268-KReg FD DisclosureMay 29, 20268-KBylaw AmendmentMay 21, 202610-Q10-QMay 12, 20268-KResults of OperationsMay 12, 20268-KExecutive ChangeMay 11, 202610-K/A10-K/AApr 28, 20268-K/ACompany UpdateApr 24, 20268-KExecutive Change · Material AgreementApr 20, 20268-KExecutive Change · Material AgreementMar 27, 202610-K10-KMar 3, 20268-KResults of Operations · Reg FD DisclosureMar 3, 20268-KResults of Operations · Reg FD DisclosureJan 9, 20268-KReg FD DisclosureNov 26, 20258-KCompany UpdateNov 21, 20258-KCompany UpdateNov 21, 20258-KReg FD Disclosure · Company UpdateNov 10, 202510-Q10-QNov 4, 20258-KResults of OperationsNov 4, 20258-KReg FD DisclosureOct 14, 20258-KReg FD Disclosure · Company UpdateSep 29, 202510-Q10-QAug 6, 20258-KResults of OperationsAug 6, 20258-KShareholder VoteJun 17, 20258-KReg FD Disclosure · Company UpdateJun 3, 202510-Q10-QMay 5, 20258-KResults of OperationsMay 5, 2025DEFA14ADEFA14AApr 29, 2025DEF 14ADEF 14AApr 29, 20258-KCompany UpdateMar 24, 202510-K10-KFeb 27, 20258-KResults of OperationsFeb 27, 20258-KReg FD DisclosureFeb 19, 20258-KReg FD Disclosure · Company UpdateFeb 12, 20258-KMaterial Agreement · Reg FD DisclosureFeb 3, 20258-KCompany UpdateDec 11, 2024424B5424B5Nov 15, 202410-Q10-QNov 5, 20248-KResults of OperationsNov 5, 20248-KMaterial AgreementAug 14, 2024424B5424B5Aug 14, 202410-Q10-QAug 5, 20248-KResults of OperationsAug 5, 2024SC 13GSC 13GJul 10, 20248-KShareholder VoteJun 12, 202410-Q10-QMay 9, 20248-KResults of OperationsMay 9, 2024SC 13GSC 13GMay 6, 2024DEFA14ADEFA14AApr 24, 2024DEF 14ADEF 14AApr 24, 202410-K10-KMar 11, 20248-KResults of OperationsMar 11, 20248-KResults of Operations · Reg FD DisclosureJan 5, 20248-KMaterial Agreement · Reg FD DisclosureNov 27, 202310-Q10-QNov 2, 20238-KResults of OperationsNov 2, 20238-KReg FD DisclosureOct 25, 20238-KReg FD DisclosureOct 10, 2023SC 13GSC 13GOct 2, 20238-KExecutive ChangeSep 18, 202310-Q10-QAug 7, 20238-KResults of OperationsAug 7, 20238-KShareholder VoteJun 15, 202310-Q10-QMay 11, 20238-KResults of OperationsMay 11, 2023DEFA14ADEFA14AApr 27, 2023DEF 14ADEF 14AApr 27, 20238-KExecutive ChangeApr 6, 202310-K10-KMar 1, 20238-KResults of OperationsMar 1, 20238-KBylaw AmendmentFeb 10, 20238-KCompany UpdateJan 13, 20238-KResults of Operations · Reg FD DisclosureJan 5, 2023424B5424B5Nov 8, 202210-Q10-QNov 8, 20228-KResults of Operations · Reg FD DisclosureNov 8, 20228-KMaterial Agreement · Reg FD DisclosureSep 12, 2022SC 13GSCHEDULE 13GSep 9, 2022
Insider Activity
In the 90 days to Mar 27, 2026: 5 sold $5.3M.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 27, 2026 | Faga DanielPresident, CEO | Sell | 3,662 | $58.62 | $215K |
| Mar 27, 2026 | Faga DanielPresident, CEO | Sell | 3,155 | $64.19 | $203K |
| Mar 27, 2026 | Faga DanielPresident, CEO | Sell | 3,038 | $65.20 | $198K |
| Mar 27, 2026 | Faga DanielPresident, CEO | Sell | 2,592 | $63.35 | $164K |
| Mar 27, 2026 | Faga DanielPresident, CEO | Sell | 2,570 | $57.91 | $149K |
| Mar 27, 2026 | Faga DanielPresident, CEO | Sell | 1,012 | $62.15 | $63K |
| Mar 27, 2026 | Faga DanielPresident, CEO | Sell | 550 | $60.63 | $33K |
| Mar 27, 2026 | Faga DanielPresident, CEO | Sell | 490 | $59.62 | $29K |
| Mar 27, 2026 | Faga DanielPresident, CEO | Sell | 510 | $56.61 | $29K |
| Mar 27, 2026 | Faga DanielPresident, CEO | Sell | 100 | $65.99 | $7K |
| Feb 11, 2026 | Loumeau Eric JCHIEF LEGAL OFFICER | Sell | 10,000 | $54.00 | $540K |
| Jan 15, 2026 | Marquet MagdaDirector | Sell | 9,290 | $48.12 | $447K |
| Jan 15, 2026 | Marquet MagdaDirector | Sell | 1,710 | $48.85 | $84K |
| Jan 8, 2026 | Faga DanielPresident, CEO | Sell | 14,281 | $44.71 | $639K |
| Jan 8, 2026 | Lizzul Paul F.Chief Medical Officer | Sell | 3,650 | $44.71 | $163K |
| Jan 8, 2026 | Mulroy DennisCHIEF FINANCIAL OFFICER | Sell | 2,515 | $44.71 | $112K |
| Jan 8, 2026 | Loumeau Eric JCHIEF LEGAL OFFICER | Sell | 2,210 | $44.71 | $99K |
| Jan 7, 2026 | Faga DanielPresident, CEO | Sell | 9,202 | $45.11 | $415K |
| Jan 7, 2026 | Loumeau Eric JCHIEF LEGAL OFFICER | Sell | 5,281 | $45.38 | $240K |
| Jan 7, 2026 | Lizzul Paul F.Chief Medical Officer | Sell | 2,235 | $45.11 | $101K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Similar companies
Comparable business profile · signals at a glance